LEGENDS
FIGURE 1 Treatment algorithm of patients with high-risk neuroblastoma. COJEC, cisplatin, vincristine, carboplatin, etoposide, cyclophosphamide; TVD, topotecan, vincristine, doxorubicin.
FIGURE 2 Flowchart illustrating treatment administered and the outcome of 28 patients with high-risk neuroblastoma. ASCT, autologous stem cell transplantation; BM, bone marrow; COJEC, cisplatin, vincristine, carboplatin, etoposide, cyclophosphamide; FN, febrile neutropenia; IQR, interquartile range; TVD, topotecan, vincristine, doxorubicin.
FIGURE 3 Survival of patients with high-risk neuroblastoma (n=28). Overall and event-free survival is similar (29.3%), as no patient with relapse was treated.